Build Momentum Tirzepatide is an FDA-approved injectable therapy that combines GLP-1 and GIP receptor activationtwo naturally occurring gut hormones that help regulate appetite, improve blood sugar, and accelerate fat loss
The timeframe for experiencing menstrual changes varies some women notice differences within the first few months, whilst others see changes only after significant weight loss (typically 5-10% of body weight or more)
It works by mimicking the GLP-1 hormone, which reduces appetite, slows gastric emptying, and improves blood sugar control
Several mechanisms may potentially contribute to blood pressure effects, including: weight loss (a well-established factor in blood pressure reduction), possible promotion of natriuresis (sodium excretion by the kidneys), and theoretical improvements in endothelial functionthough many of these mechanisms remain hypothetical rather than definitively proven
True treatment failure differs from expected plateaus
Int J Cosmetic Sci (2011) 33(3):21021